You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 10,239,867


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,239,867
Title:Modulators of ATP-binding cassette transporters
Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
Inventor(s): Hadida Ruah; Sara S. (La Jolla, CA), Grootenhuis; Peter D. J. (San Diego, CA), Van Goor; Fredrick (San Diego, CA), Zhou; Jinglan (San Diego, CA), Bear; Brian (Oceanside, CA), Miller; Mark T. (San Diego, CA), McCartney; Jason (Cardiff by the Sea, CA), Numa; Mehdi Michel Jamel (San Diego, CA), Yang; Xiaoqing (San Diego, CA)
Assignee: Vertex Pharmaceuticals Incorporated (Boston, MA)
Application Number:15/659,926
Patent Claims: 1. A compound of formula IId: ##STR00788## or a pharmaceutically acceptable salt thereof; wherein both R.sub.2 groups, together with the atoms to which they are attached, form the group: ##STR00789## R'.sub.3 is selected from --CH.sub.2CH.sub.2 and ##STR00790## and each R.sub.3 is independently selected from ##STR00791## H, and F.

2. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein R'.sub.3 is: ##STR00792##

3. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein one occurrence of R.sub.3 is fluoro.

4. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein one occurrence of R.sub.3 is ##STR00793##

5. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein one R.sub.3 is fluoro and one R.sub.3 is ##STR00794##

6. The compound of claim 1 or a pharmaceutically acceptable salt thereof; wherein both R.sub.2 groups, together with the atoms to which they are attached, form the group: ##STR00795## R'3 is ##STR00796## and one R.sub.3 is fluoro and one R.sub.3 is ##STR00797##

7. A pharmaceutical composition comprising a compound or a pharmaceutically acceptable salt thereof as described in claim 1, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.

8. The pharmaceutical composition of claim 7 or a pharmaceutically acceptable salt thereof, wherein the composition further comprises one or more additional therapeutic agents.

9. A pharmaceutical composition comprising a compound or a pharmaceutically acceptable salt thereof as described in claim 6, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.

10. The pharmaceutical composition of claim 9 or a pharmaceutically acceptable salt thereof, wherein the composition further comprises one or more additional therapeutic agents.

11. A method of treating or lessening the severity of cystic fibrosis in a patient, comprising the step of administering to a patient an effective amount of a compound or a pharmaceutically acceptable salt thereof according to claim 1.

12. A method of treating or lessening the severity of cystic fibrosis in a patient, comprising the step of administering to a patient an effective amount of a compound or a pharmaceutically acceptable salt thereof according to claim 6.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.